VISCHER AG
VISCHER is a Swiss business law and tax firm with particular strength at the intersection of capital markets and life sciences. The firm advises pharmaceutical, biotechnology and medical technology companies, investors and listed companies on financings, IPOs, securities listings, strategic transactions and ongoing capital markets requirements.
- Capital markets and life sciences: Extensive experience advising pharmaceutical, biotechnology and medical technology companies and their investors on financings, IPOs, securities listings and strategic transactions.
- SIX expertise combined with sector knowledge: Recognised representatives of issuers before SIX Swiss Exchange, supported by multidisciplinary teams combining capital markets expertise with established life sciences, corporate, regulatory, tax and financing capabilities.
- Experience throughout the listed-company lifecycle: Advice from IPO preparation and securities listings through to ongoing disclosure and reporting obligations, corporate governance and shareholder matters.
Company Profile
- Schützengasse 1, 8021, Zürich
- Founded January 1857
- Offices: Zurich, Basel, Geneva
- 250 Employees
- German, English, French
- https://www.vischer.com/
VISCHER is a Swiss business law and tax firm with offices in Zurich, Basel and Geneva and almost 170 years of experience. The firm advises listed and privately held companies, financial institutions, investors, shareholders and governing bodies on complex domestic and cross-border matters. A particular strength of VISCHER lies at the intersection of capital markets and life sciences. The firm has extensive experience advising pharmaceutical, biotechnology and medical technology companies, as well as their investors, throughout their corporate development – from financing rounds and strategic transactions to IPOs, securities listings and the ongoing requirements of listed companies. VISCHER’s Capital Markets team supports clients throughout the corporate lifecycle, from IPO preparation, securities listings and financing transactions to ongoing disclosure and reporting obligations, corporate governance, shareholder meetings, public takeovers, proxy solicitations and strategic transactions. By combining Capital Markets expertise with its established Life Sciences practice and specialists in Corporate/M&A, Banking and Finance, Tax, Employment, Competition, Technology and Dispute Resolution, VISCHER provides coordinated advice on both the transaction and the sector-specific legal and regulatory environment. The team includes representatives of issuers recognised by the Regulatory Board of SIX Swiss Exchange.